Dr. Kinney has served as our President and CEO since 2016. Prior to being appointed to this position he was Chief Operating Officer and Chief Scientific Officer. Dr. Kinney is a member of Prothena’s founding leadership team, and between 2012 and 2016 held the position of Chief Scientific Officer and Head of Research and Development. Before joining Prothena, Dr. Kinney held positions with Elan Pharmaceuticals Inc., including Senior Vice President of Pharmacological Sciences (a position he held from 2011 to 2012), and Vice President, Pharmacology (a position he held from 2009 to 2011); while in those positions, Dr. Kinney also served as Head of Nonclinical Research for Janssen Alzheimer Immunotherapy. Before joining Elan, Dr. Kinney held several senior positions at Merck Research Laboratories and Bristol Myers Squibb, and was an Assistant Professor at the Emory University School of Medicine. Dr. Kinney earned his BA from Bloomsburg University and his MA and PhD from Florida Atlantic University. Dr. Kinney has served on our Board since September 2016.